| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/30/2011 | US20110159068 Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic support |
| 06/30/2011 | US20110158974 Heterodimeric Meganucleases and Use Thereof |
| 06/30/2011 | US20110158972 Compositions and methods for treating collagen-mediated diseases |
| 06/30/2011 | US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof |
| 06/30/2011 | US20110158947 Sulfonylurea receptor and means for treating ischaemia |
| 06/30/2011 | CA2785668A1 Aminopyridine compound |
| 06/30/2011 | CA2785360A1 Treating critically ill patients with intravenous ibuprofen |
| 06/30/2011 | CA2785284A1 Novel aryl urea derivative |
| 06/30/2011 | CA2785191A1 Crth2 modulators |
| 06/30/2011 | CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/29/2011 | EP2339020A1 Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A) |
| 06/29/2011 | EP2338899A1 Peptides for activation and inhibition of delta PKC |
| 06/29/2011 | EP2338887A1 Fused heterocyclic derivative and use thereof for medical purposes |
| 06/29/2011 | EP2338886A2 Naphthalene derivatives |
| 06/29/2011 | EP2338519A1 Agent for treating myelofibrosis |
| 06/29/2011 | EP2338517A1 Method for treatment or prevention of disease associated with functional disorder of regulatory T cell |
| 06/29/2011 | EP2338483A2 Method and preparation preventing and/or treating neurodegenerative or neurological disorders using choline |
| 06/29/2011 | EP2039354B1 Compounds blocking the nmda receptor channel and pharmaceutical agent using the same |
| 06/29/2011 | EP1849774B1 CYCLOHEPTA(b)PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME |
| 06/29/2011 | EP1503788B1 Treatment of alpha-galactosidase a deficiency |
| 06/29/2011 | EP1435786B1 Pesticidal formulations |
| 06/29/2011 | EP1379225B1 Novel medicament compositions based on anticholinergic agents and endothelin antagonists |
| 06/29/2011 | EP1326834B1 2-substituted heterocyclic compounds |
| 06/29/2011 | EP1233958B1 Inhibitors of histone deacetylase |
| 06/29/2011 | EP1233943B1 Ionizable indolinone derivatives and their use as ptk ligands |
| 06/29/2011 | EP1114151B1 G protein-coupled receptor antagonists |
| 06/29/2011 | CN1989963B Pharmaceutical compositions |
| 06/29/2011 | CN1427889B Hybrid cells obtainable from antigen presenting cells |
| 06/29/2011 | CN102112462A Aminopropylidene derivative |
| 06/29/2011 | CN102112136A Composition for inhibiting expression of target gene |
| 06/29/2011 | CN102108079A 4-anilino quinazoline derivatives serving as tyrosine kinase inhibitors |
| 06/29/2011 | CN102107000A Application of cholecystokinin octapeptide in pharmacy |
| 06/29/2011 | CN102106863A Water sprinkling anti-stress agent for aquaculture |
| 06/29/2011 | CN102106849A Novel medicinal application of baicalein |
| 06/29/2011 | CN102106805A Cymipristone solid preparation and preparation methods thereof |
| 06/29/2011 | CN101048180B Solid formulation with improved solubility and stability, and method for producing said formulation |
| 06/28/2011 | US7968716 Caspase inhibitors and uses thereof |
| 06/28/2011 | US7968707 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | US7968523 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides |
| 06/28/2011 | US7968336 Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| 06/28/2011 | US7968303 Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1) |
| 06/28/2011 | US7968099 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
| 06/28/2011 | CA2470656C Corticotropin releasing factor 2 receptor agonists |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/28/2011 | CA2445834C Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 06/28/2011 | CA2427206C Sulfamides as gamma-secretase inhibitors |
| 06/28/2011 | CA2380305C Streptogramin derivatives, production thereof and compositions containing the same |
| 06/28/2011 | CA2315976C Serine protease inhibitors |
| 06/23/2011 | WO2011074564A1 Method of producing adenovirus vectors |
| 06/23/2011 | WO2011074560A1 Oxadiazole derivative having endothelial lipase inhibitory activity |
| 06/23/2011 | WO2011073981A2 Compositions and methods for treating somnolence |
| 06/23/2011 | WO2011073419A1 New steroid inhibitors of pgp for use for inhibiting multidrug resistance |
| 06/23/2011 | WO2011073229A1 Compositions comprising alginates with high guluronic acid/mannuronic acid ratio for use in the treatment of dentine hypersensitivity |
| 06/23/2011 | WO2011072483A1 Compositions and methods for controlling proliferation and differentiation cells |
| 06/23/2011 | WO2011027344A3 Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders |
| 06/23/2011 | US20110153302 Identification of drug effects on signaling pathways using integer linear programming |
| 06/23/2011 | US20110152359 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising threreof |
| 06/23/2011 | US20110152307 Ophthalmic composition comprising ascomycin |
| 06/23/2011 | US20110152291 Novel aromatic compounds and their use in medical applications |
| 06/23/2011 | US20110152288 Methods of treating vasomotor symptoms |
| 06/23/2011 | US20110152234 Novel Compounds |
| 06/23/2011 | US20110152218 Crystalline phospholipid, method for its production and use in treating damaged tissue |
| 06/23/2011 | US20110152215 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 06/23/2011 | US20110152213 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 06/23/2011 | US20110152171 Histamine binding protein |
| 06/23/2011 | US20110152168 Antiadhesive carbohydrates |
| 06/23/2011 | US20110151579 Secreted Epithelial Stromal-1 Molecules and Uses Thereof |
| 06/23/2011 | US20110151472 Novel means for the diagnosis and therapy of ctcl |
| 06/23/2011 | US20110151014 Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients |
| 06/23/2011 | US20110150968 Dissolvable dietary supplement strip and methods for using the same |
| 06/23/2011 | US20110150944 Structured triglycerides and emulsions comprising same |
| 06/23/2011 | US20110150924 Device, Method, and system for neural modulation as vaccine adjuvant in a vertebrate subject |
| 06/23/2011 | US20110150899 Senescence control composition containing extracellular matrix components, and senescence control method for senescent cells using same |
| 06/23/2011 | US20110150877 Ephrin-b receptor protein involved in carcinoma |
| 06/23/2011 | US20110150861 Sorf constructs and multiple gene expression |
| 06/23/2011 | US20110150850 Reduced colonization of microbes at the mucosa |
| 06/23/2011 | US20110150848 Cell Suspension Preparation Technique and Device |
| 06/23/2011 | US20110150842 Derivation of Embryonic Stem Cells |
| 06/23/2011 | US20110150779 Dynamic nuclear polarization enhanced nuclear magnetic resonance of water under ambient conditions |
| 06/23/2011 | US20110150778 Assembly of Gas-Filled Microvesicle With Active Component For Contrast Imaging |
| 06/23/2011 | US20110150777 Magnetic resonance tomography imaging |
| 06/23/2011 | US20110150775 Genomic approaches to fetal treatment and diagnosis |
| 06/23/2011 | US20110145970 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8 |
| 06/23/2011 | CA2784710A1 Oxadiazole derivative having endothelial lipase inhibitory activity |
| 06/23/2011 | CA2782569A1 Compositions comprising alginates with high guluronic acid/mannuronic acid ratio for use in the treatment of dentine hypersensitivity |
| 06/22/2011 | EP2336301A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336300A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336299A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 06/22/2011 | EP2336187A2 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 06/22/2011 | EP2336169A1 G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| 06/22/2011 | EP2336165A1 Peptides and compounds that bind to the thrombopoietin receptor |
| 06/22/2011 | EP2336144A1 Esterified alpha-galactosylceramide |
| 06/22/2011 | EP2336134A1 Fitness assay and methods for reducing resistance of HIV to therapy |
| 06/22/2011 | EP2336133A1 Purine analogs having HSP90-inhibiting activity |
| 06/22/2011 | EP2336132A1 Morpholinopurine derivative |
| 06/22/2011 | EP2336124A1 Stable hydrate of a muscarinic receptor antagonist |
| 06/22/2011 | EP2336109A1 Novel pyrrolinone derivative and medicinal composition containing same |
| 06/22/2011 | EP2336107A2 Proton pump inhibitors |